Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®

Clinical Evaluation of FLACS (Femtosecond Laser Assisted Cataract Surgery) With Combination of LenSx® and Centurion®

The purpose of this study is to evaluate cumulative dissipated energy (CDE), endothelial cell loss, and average torsional amplitude with combination of LenSx® and Centurion® compared to conventional cataract surgery.

Subjects will attend 7 scheduled visits: 1 pre-operative, 1 operative, and 5 post-operative.

Inclusion Criteria:

• Cataracts (Grade 2-4 of Emery-Little Classification) with planned cataract removal by phacoemulsification in both eyes;
• Able to comprehend and willing to sign informed consent and complete all required postoperative follow-up procedures;
• Calculated lens power within the available range;
• Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

• Any pathology that could reduce visual potential;
• Hypotony or the presence of a corneal implant;
• Residual, recurrent, active ocular or eyelid disease;
• Poorly dilating pupil;
• Any contraindication to cataract;
• Eyes with two different levels of cataract grade;
• Pregnant, or planned pregnancy during the study;
• Expected to require an ocular surgical treatment at any time during the study;
• Other protocol-specified exclusion criteria may apply.